The National Cancer Institute (NCI) has renewed the comprehensive designation for the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine for another five years. The renewal includes $18 million in grant funding. The NCI’s comprehensive …

HARMONi-GI3 is the Fourth Global Phase III Study of Ivonescimab and First Global Study beyond NSCLC Clinical Trial Site Activations Planned to Begin This Quarter in the United States Conference Call to be Held at 8:00am ET on Monday, October 20, 2025 …

Google has announced DeepSomatic, an AI tool that can identify cancer-related mutations in tumour genetic sequences more accurately. Cancer starts when the controls governing cell division malfunction. Finding the specific genetic mutations driving a …

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients – and found a potential way to overcome that resistance. Team members identified a protein that lets cancer cells reshape …

Around four years ago, now 77-year-old John Gormly went for what was supposed to be a routine blood test. But the results were life-changing. The test suggested Gormly had colon cancer, which a colonoscopy later confirmed was Stage 2, meaning the cancer …

… prognosis. Up to 4% of lung cancers are driven by HER2 (ERBB2 … NSCLC. Up to 4% of lung cancers are driven by HER2 (ERBB2 … ;en (Accessed: October 2025).  6 National Cancer Institute Surveillance, Epidemiology, and End Results …

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the Phase 3 monarchE trial also show Verzenio plus endocrine …

When the organization now called the European Society for Medical Oncology (ESMO) opens its 50th anniversary Congress tomorrow in Berlin, Germany, it will showcase a city that has reinvented itself in the decades since that first gathering of French, …

The Indiana University School of Medicine is a major research hub for diseases like cancer, Alzheimer's, and diabetes. Recent federal funding cuts have abruptly slashed millions from research grants for Indiana universities. The column highlights …

Jing Zhu,1,* Yu-Suo Tong,2,* Wei-Guo Zhu,2 Wan-Wei Wang,2 Fu-Zhi Ji,2 Xi-Lei Zhou2 1Department of Oncology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, People’s Republic of China; 2Department of …